Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Core decompression ± Iloprost for non-traumatic avascular necrosis of the femoral head
DRKS00022404Phase 2Terminated
- Sponsor
- Leipzig University
- Start
- Aug 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in osteonecrosis of the hip, osteonecrosis and Secondary Osteonecrosis (SON) comparing Core decompression plus Iloprost with Core decompression plus placebo (2 arms). Started Aug 2021; status: terminated.
02
Drugs
iloprost
03
Conditions
osteonecrosis of the hiposteonecrosisSecondary Osteonecrosis (SON)
Beyond the preview
Go deeper on DRKS00022404.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00022404.